The Channel
Innovate Retina TV.
Late-breaking data and expert takes, between the meetings.
Late-breaking clinical trial dataInnovate Retina PBM Intro
Diana V. Do, MD and colleagues discuss late-breaking data from the LIGHTSIGHT III clinical trial on photobiomodulation (PBM) in dry AMD, with a high-level overview of PBM technology.
Late-breaking clinical trial dataInnovate Retina PBM Panel
Will this technology provide meaningful improvements in patients' vision?
Experts weigh in on new dataWill FDA Approve Pegcetacoplan?
Hear what the experts have to say live from the Retina Society Meeting in this 5-minute video.
KOL interviewsKOL Interviews: Will FDA Approve Pegcetacoplan
KOL videos live from the Retina Society Meeting in this 15-minute video.
Efficacy and safety data summaryOAKS and DERBY: Efficacy and Safety Data Summary
OAKS and DERBY efficacy and safety data live from the Retina Society Meeting in this 11-minute video.
Each video opens on YouTube in a new tab.